Partnership
SCOLI Portfolio — ScoliGEN & ScoliVIEW IVD tools for adolescent idiopathic scoliosis
First precision IVD portfolio for AIS: saliva-based genetic risk test (ScoliGEN, LDT available) + AI Cobb angle tool (ScoliVIEW, ICC 0.97). CE-IVD 2026. $1.7B TAM, no competitors. Seeking out-licensing & distribution partners.